Regorafenib in metastatic colorectal cancer

MeSH terms

• Antineoplastic Agents / adverse effects
• Antineoplastic Agents / therapeutic use*
• Clinical Trials, Phase III as Topic
• Colorectal Neoplasms / drug therapy*
• Colorectal Neoplasms / pathology*
• Humans
• Neoplasm Metastasis
• Palliative Care
• Phenylurea Compounds / adverse effects
• Phenylurea Compounds / therapeutic use*
• Pyridines / adverse effects
• Pyridines / therapeutic use*
• Research / trends
• Research Design
• Treatment Outcome